Bill

Bill > HR2209


US HR2209

US HR2209
Fixing Global Freeloading Act


summary

Introduced
04/10/2019
In Committee
04/10/2019
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

116th Congress

Bill Summary

To establish the position of Chief Pharmaceutical Negotiator in the Office of the United States Trade Representative responsible for conducting trade negotiations and enforcing trade agreements related to acts, policies, and practices of foreign governments that fail to appropriately reward United States innovation with respect to pharmaceuticals, and for other purposes. This bill establishes the position of Chief Pharmaceutical Negotiator in the Office of the U.S. Trade Representative. The Chief Pharmaceutical Negotiator must conduct trade negotiations and enforce trade agreements related to pharmaceutical products and services.

AI Summary

This bill establishes the position of Chief Pharmaceutical Negotiator in the Office of the U.S. Trade Representative. The Chief Pharmaceutical Negotiator is responsible for conducting trade negotiations and enforcing trade agreements related to acts, policies, and practices of foreign governments that fail to appropriately reward U.S. innovation with respect to pharmaceuticals. The bill finds that international government price controls on pharmaceutical products and services create an unfair playing field, as the U.S. bears the cost of developing innovative and life-saving drugs while other countries refuse to pay their fair share. The Chief Pharmaceutical Negotiator is tasked with being a vigorous advocate for U.S. pharmaceutical interests and must submit annual reports to Congress describing enforcement actions and other efforts to advance U.S. pharmaceutical products and services.

Committee Categories

Budget and Finance, Business and Industry

Sponsors (6)

Last Action

Referred to the Subcommittee on Trade. (on 04/10/2019)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...